Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells

Oncogene

Volumn 29, Issue 22, 2010, Pages 3217-3227

  Matrone, M A ^a,c   Whipple, R A ^b   Thompson, K ^b   Cho, E H ^a,c   Vitolo, M I ^b   Balzer, E M ^a   Yoon, J R ^a   Ioffe, O B ^a   Tuttle, K C ^b   Tan, M ^a,b   Martin, S S ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Circulating tumor cells; Microtentacles; Microtubule associated proteins; Microtubules; Tau

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN; TUBULIN;

ARTICLE; BREAST CANCER; CELL ADHESION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; METASTASIS; MICROTUBULE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL; BIOSYNTHESIS; BREAST NEOPLASMS; CYTOSKELETON; FEMALE; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR INVASION; VASCULARIZATION;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CYTOSKELETON; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TAU PROTEINS; TUBULIN; TUMOR CELLS, CULTURED;

EID: 77953232401     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.68     Document Type: Article

References (41)

1. Atienza JM, Yu N, Kirstein SL, Xi B, Wang X, Xu X et al. (2006). Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol 4: 597-607.
2. Balzer EM, Whipple RA, Cho EH, Matrone MA, Martin SS. (2009). Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells. Breast Cancer Res Treat (e-pub ahead of print 11 July 2009)
3. Bhat KM, Setaluri V. (2007). Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 13: 2849-2854.
4. Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E. (2009). Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 48: 1740-1752.
5. Camara O, Rengsberger M, Egbe A, Koch A, Gajda M, Hammer U et al. (2007). The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol 18: 1484-1492.
6. Cassimeris L, Spittle C. (2001). Regulation of microtubule-associated proteins. Int Rev Cytol 210: 163-226.
7. Chen J, Kanai Y, Cowan NJ, Hirokawa N. (1992). Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360: 674-677.
8. Dickey CA, Ash P, Klosak N, Lee WC, Petrucelli L, Hutton M et al. (2006). Pharmacologic reductions of total tau levels; implications for the role of microtubule dynamics in regulating tau expression. Mol Neurodegener 1: 6.
9. Drubin DG, Feinstein SC, Shooter EM, Kirschner MW. (1985). Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J Cell Biol 101: 1799-1807.
10. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ. (1978). Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 38: 3352-3364.
11. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M et al. (1998). Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78: 766-774.
12. Goedert M. (2004). Tau protein and neurodegeneration. Semin Cell Dev Biol 15: 45-49.
13. Haier J, Nicolson GL. (2001). Tumor cell adhesion under hydro-dynamic conditions of fluid flow. Apmis 109: 241-262.
14. Hall A. (2009). The cytoskeleton and cancer. Cancer Metastasis Rev 28: 5-14.
15. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68.
16. Ingber DE. (2003). Tensegrity I Cell structure and hierarchical systems biology. J Cell Sci 116: 1157-1173.
17. Janmey PA, Euteneuer U, Traub P, Schliwa M. (1991). Viscoelastic properties of vimentin compared with other filamentous biopolymer networks. J Cell Biol 113: 155-160.
18. Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S et al. (2005). The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 103: 884-891. (Pubitemid 40270064)
19. Knops J, Kosik KS, Lee G, Pardee JD, Cohen-Gould L, McConlogue L. (1991). Overexpression of tau in a nonneuronal cell induces long cellular processes. J Cell Biol 114: 725-733.
20. Korb T, Schluter K, Enns A, Spiegel HU, Senninger N, Nicolson GL et al. (2004). Integrity of actin fibers and microtubules influences metastatic tumor cell adhesion. Exp Cell Res 299: 236-247.
21. Lee G, Rook SL. (1992). Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J Cell Sci 102(part 2): 227-237.
22. Levy SF, Leboeuf AC, Massie MR, Jordan MA, Wilson L, Feinstein SC. (2005). Three-and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration. J Biol Chem 280: 13520-13528.
23. McGrogan BT, Gilmartin B, Carney DN, McCann A. (2008). Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 1785: 96-132.
24. Mialhe A, Lafanechere L, Treilleux I, Peloux N, Dumontet C, Bremond A et al. (2001). Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res 61: 5024-5027.
25. Panda D, Samuel JC, Massie M, Feinstein SC, Wilson L. (2003). Differential regulation of microtubule dynamics by three-and four-repeat tau: implications for the onset of neurodegenerative disease. Proc Natl Acad Sci USA 100: 9548-9553.
26. Pusztai L, Jeong JH, Gong Y, Ross JS, Kim C, Paik S et al. (2009). Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. J Clin Oncol 27: 4287-4292.
27. Remmerbach TW, Wottawah F, Dietrich J, Lincoln B, Wittekind C, Guck J. (2009). Oral cancer diagnosis by mechanical phenotyping. Cancer Res 69: 1728-1732.
28. Rosenberg KJ, Ross JL, Feinstein HE, Feinstein SC, Israelachvili J. (2008). Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesis. Proc Natl Acad Sci USA 105: 7445-7450.
29. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J et al. (2005). Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA 102: 8315-8320.
30. Schaap IA, Hoffmann B, Carrasco C, Merkel R, Schmidt CF. (2007). Tau protein binding forms a 1 nm thick layer along protofilaments without affecting the radial elasticity of microtubules. J Struct Biol 158: 282-292.
31. Sharma VM, Litersky JM, Bhaskar K, Lee G. (2007). Tau impacts on growth-factor-stimulated actin remodeling. J Cell Sci 120: 748-757.
32. Steeg PS. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
33. Steeg PS, Theodorescu D. (2008). Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5: 206-219.
34. Thomas SM, Brugge JS. (1997). Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609.
35. Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L. (2005). Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle 4: 1149-1152.
36. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. (1975). A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72: 1858-1862.
37. Weiss L. (1991). Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency. Cell Biophys 18: 73-79.
38. Whipple RA, Balzer EM, Cho EH, Matrone MA, Yoon JR, Martin SS. (2008). Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res 68: 5678-5688.
39. Whipple RA, Cheung AM, Martin SS. (2007). Detyrosinated microtubule protrusions in suspended mammary epithelial cells promote reattachment. Exp Cell Res 313: 1326-1336.
40. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G et al. (2005). Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 11: 8006-8014.
41. Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H et al. (2006). Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 66: 4208-4214.